The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...

The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...

A positive response to treatment for pediatric obesity has enduring health benefits into young adulthood, according to study findings.